Literature DB >> 10517306

Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications.

A Ceriello1.   

Abstract

It is generally accepted that high glucose levels for many years are a primary cause of most long-term complications in diabetic patients. Many studies suggest that the central features of diabetic complications are caused by the hyperglycaemia-accelerated formation of non-enzymatic glycated products. Non-enzymatic glycation, however, has been recently demonstrated to be linked to glucose auto-oxidative process. At the same time glycated proteins have been shown to be a source of free radicals. These findings raised the hypothesis of a link between oxidative stress and the development of diabetic complications. Some studies have recently demonstrated that antioxidants, such as vitamin C and E, may reduce in vitro and in vivo protein glycation. At the same time some antioxidants act as scavengers of the free radicals produced by non-enzymatic glycation in vitro. Such studies may lead to therapeutic approaches for limiting the damage from glycation and oxidation reactions and for complementing existing therapy for treatment of the complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10517306

Source DB:  PubMed          Journal:  Diabetes Nutr Metab        ISSN: 0394-3402


  15 in total

1.  Evaluation of Oxidative Stress in Type 2 Diabetes Mellitus and Follow-up Along with Vitamin E Supplementation.

Authors:  Sarita N Shinde; Vithal N Dhadke; Adinath N Suryakar
Journal:  Indian J Clin Biochem       Date:  2010-12-22

Review 2.  Is there a clinical role for oxidative stress biomarkers in atherosclerotic diseases?

Authors:  Daniele Pastori; Roberto Carnevale; Pasquale Pignatelli
Journal:  Intern Emerg Med       Date:  2013-09-22       Impact factor: 3.397

3.  Effects of aminoguanidine and vitamin C on collagen type IV in diabetic nephropathy rats.

Authors:  Qiangxiang Li; Xiang Ao; Youhong Du; Yang Li; Yangshi Ou; Raofeng Gong; Xuexiong Sun; Yi Xiang Yang; Gebo Wen
Journal:  Endocrine       Date:  2010-11-18       Impact factor: 3.633

Review 4.  Endothelial dysfunction in diabetes.

Authors:  A S De Vriese; T J Verbeuren; J Van de Voorde; N H Lameire; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

5.  Featured Article: Oxidative stress status and liver tissue defenses in diabetic rats during intensive subcutaneous insulin therapy.

Authors:  Stéphanie Dal; Nathalie Jeandidier; Elodie Seyfritz; William Bietiger; Claude Péronet; François Moreau; Michel Pinget; Elisa Maillard; Séverine Sigrist
Journal:  Exp Biol Med (Maywood)       Date:  2015-09-18

Review 6.  Antioxidant vitamins and their influence in diabetes mellitus.

Authors:  Bibi Hasanain; Arshag D Mooradian
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

7.  Suppression of methylglyoxal hyperactivity by mangiferin can prevent diabetes-associated cognitive decline in rats.

Authors:  Yao-Wu Liu; Xia Zhu; Qian-Qian Yang; Qian Lu; Jian-Yun Wang; Hui-Pu Li; Ya-Qin Wei; Jia-Le Yin; Xiao-Xing Yin
Journal:  Psychopharmacology (Berl)       Date:  2013-03-26       Impact factor: 4.530

8.  Pycnogenol for diabetic retinopathy. A review.

Authors:  F Schönlau; P Rohdewald
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

9.  Effect of acarbose on platelet-derived microparticles, soluble selectins, and adiponectin in diabetic patients.

Authors:  Takayuki Shimazu; Norihito Inami; Daisuke Satoh; Takayuki Kajiura; Kohichi Yamada; Toshiji Iwasaka; Shosaku Nomura
Journal:  J Thromb Thrombolysis       Date:  2009-01-10       Impact factor: 2.300

10.  Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat.

Authors:  N L Alderson; M E Chachich; N Frizzell; P Canning; T O Metz; A S Januszewski; N N Youssef; A W Stitt; J W Baynes; S R Thorpe
Journal:  Diabetologia       Date:  2004-07-28       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.